Advances in Hepatocellular Carcinoma (HCC): Key Updates from AASLD 2023 and Beyond

Anwaar Saeed, MD, and Amit Singal, MD, explore recent updates in the treatment of advanced hepatocellular carcinoma (HCC) presented at the 2023 AASLD: The Liver Meeting Congress and surrounding meetings.

EP. 1: The Evolving Landscape of Hepatocellular Carcinoma

December 12th 2023

Anwaar Saeed, MD, and Amit Singal, MD, discuss the evolving treatment landscape for hepatocellular carcinoma, highlighting FDA approvals and the utility of clinical biomarkers.

EP. 2: Atezolizumab plus Bevacizumab in the Treatment of Unresectable HCC

December 12th 2023

A comprehensive review of clinical data of atezolizumab plus bevacizumab for the treatment of unresectable HCC.

EP. 3: AASLD 2023 Updates: HIMALAYA Trial for uHCC

December 19th 2023

Dr. Saeed outlines the use of combination tremelimumab plus durvalumab in uHCC, discussing updates from the HIMALAYA trial presented at AASLD 2023.

EP. 4: Efficacy and Safety Outcomes in Combination Immunotherapy for uHCC

December 19th 2023

An expert analysis in data surrounding treatment outcomes in combination regimens, noting immune-mediate adverse events and overall impact on treatment response.

EP. 5: Real-World Data and Impact on Treatment Selection in uHCC

December 26th 2023

Expert oncologists review real-world data and discuss the impact on treatment selection in uHCC.

EP. 6: Additional Data Updates from AASLD 2023

December 26th 2023

Drs Saeed and Singal discuss additional data presented at AASLD 2023 related to frontline systemic therapies and emerging combinations in unresectable HCC.

EP. 7: Future Directions in the Management of Hepatocellular Carcinoma

January 2nd 2024

To close, Dr. Saeed and Dr. Singal share their excitement for the future landscape, emerging agents and treatment strategies for patients with HCC.